-
Share
1,174 Posts.
588
23/02/14
14:44
Share
Is US money pouring into Benitec?
Tracking the US market stats for listed companies in the RNAi space, it would seem not.
Let's see what happened on Friday.
This is a list of the value of trades (at closing prices) in the eight companies listed today by success41:
Alnylam $US105.1m
Arrowhead $49.7m
Tekmira $20.3m
Dicerna $5.7m
Marina $1.24m
Benitec $1.07m
RXi $756,619
Bio-Path $50,273
Total = $US185m
Share attributable to Bentitec/BNIKF: 0.6pc
Which poses a question: Given the level of American interest in the RNAi sector why is Benitec/BNIKF being so emphatically ignored?
-